Xylem Inc. $XYL Position Increased by Vontobel Holding Ltd.

Vontobel Holding Ltd. raised its stake in Xylem Inc. (NYSE:XYL) by 3.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 717,049 shares of the industrial products company’s stock after buying an additional 25,182 shares during the period. Vontobel Holding Ltd.’s holdings in Xylem were worth $105,765,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Norges Bank bought a new stake in shares of Xylem during the 2nd quarter worth $338,232,000. ABN AMRO Bank N.V. purchased a new stake in shares of Xylem during the second quarter valued at $208,226,000. Amundi boosted its position in shares of Xylem by 17.0% in the 2nd quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock valued at $730,717,000 after purchasing an additional 830,337 shares during the period. Voya Investment Management LLC increased its stake in Xylem by 544.0% in the 3rd quarter. Voya Investment Management LLC now owns 868,755 shares of the industrial products company’s stock worth $128,141,000 after purchasing an additional 733,860 shares in the last quarter. Finally, Vanguard Group Inc. raised its holdings in Xylem by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 29,697,829 shares of the industrial products company’s stock worth $3,841,711,000 after buying an additional 691,285 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Stock Down 0.4%

Xylem stock opened at $138.55 on Wednesday. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $154.27. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.50 and a current ratio of 1.96. The firm has a market cap of $33.73 billion, a PE ratio of 35.62, a P/E/G ratio of 2.16 and a beta of 1.18. The firm’s 50 day moving average price is $143.60 and its two-hundred day moving average price is $139.70.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The company had revenue of $2.27 billion during the quarter, compared to analyst estimates of $2.22 billion. During the same quarter last year, the business posted $1.11 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, research analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend was Tuesday, November 25th. Xylem’s dividend payout ratio is presently 41.13%.

Insider Transactions at Xylem

In related news, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the transaction, the executive vice president owned 31,250 shares of the company’s stock, valued at approximately $4,770,000. This trade represents a 25.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction that occurred on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This trade represents a 9.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.27% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Zacks Research cut shares of Xylem from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Royal Bank Of Canada boosted their price target on shares of Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Argus set a $170.00 price objective on shares of Xylem in a research note on Wednesday, October 29th. Weiss Ratings reissued a “buy (b)” rating on shares of Xylem in a research note on Monday, December 15th. Finally, Citigroup raised their target price on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $167.40.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.